TH0801002717B - An anti-fatigue agent and an orally administered composition containing andrographolide as the active ingredient. - Google Patents

An anti-fatigue agent and an orally administered composition containing andrographolide as the active ingredient.

Info

Publication number
TH0801002717B
TH0801002717B TH0801002717A TH0801002717A TH0801002717B TH 0801002717 B TH0801002717 B TH 0801002717B TH 0801002717 A TH0801002717 A TH 0801002717A TH 0801002717 A TH0801002717 A TH 0801002717A TH 0801002717 B TH0801002717 B TH 0801002717B
Authority
TH
Thailand
Prior art keywords
active ingredient
composition containing
orally administered
administered composition
fatigue agent
Prior art date
Application number
TH0801002717A
Other languages
Thai (th)
Other versions
TH145974A (en
Inventor
อาซามิคาโยะ ไซโตะอาคิฟูมิ มาเอดะโนริฟูมิ ทาเตชิ ซูมิโอะ
Original Assignee
ซันโตรี โฮลดิ้งส์ ลิมิเต็ด
Filing date
Publication date
Application filed by ซันโตรี โฮลดิ้งส์ ลิมิเต็ด filed Critical ซันโตรี โฮลดิ้งส์ ลิมิเต็ด
Publication of TH0801002717B publication Critical patent/TH0801002717B/en
Publication of TH145974A publication Critical patent/TH145974A/en

Links

TH801002717A 2008-05-30 Anti-fatigue agents and oral components containing andrografolides as active ingredients. TH145974A (en)

Publications (2)

Publication Number Publication Date
TH0801002717B true TH0801002717B (en) 2016-03-04
TH145974A TH145974A (en) 2016-03-04

Family

ID=

Similar Documents

Publication Publication Date Title
BRPI0806531A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, THERAPEUTIC AGENT, AND USE OF THE COMPOUND.
BR112012004335A2 (en) compound, pharmaceutical composition, and use of the compound.
CL2007001992A1 (en) COMPOUNDS DERIVED FROM PYRIMIDILCICLOPENTANOS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE TREATMENT OF AN INFLAMMATORY, HYPERPROLIFERANT, CARDIOVASCULAR, NEURODEGE DISEASE
BRPI0922435A2 (en) "sirtuine modulatory thiazolopyridine compound, pharmaceutical composition comprising the same and its use."
BRPI0910503A2 (en) compounds, pharmaceutical compositions and their uses.
BRPI0814593A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND.
BRPI1010772A2 (en) compound and pharmaceutical composition.
CL2007001993A1 (en) COMPOUNDS DERIVED FROM HYDROXYLATED AND METOXYLATED PYRIMIDILCICLOPENTANOS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND IN THE TREATMENT OF AN INFLAMMATORY, HYPERPROLIFERANT, CARDIOVASCULAR, NEURODEGENERAT DISEASE
BRPI0906962A2 (en) Compound and pharmaceutical composition
BRPI0906556A2 (en) Compound and pharmaceutical composition
EP2130552A4 (en) Pharmaceutical composition comprising anti-grp78 antibody as active ingredient
IL206808A (en) Indolyl-pyridone derivatives, pharmaceutical compositions comprising the same and uses thereof
BRPI0908097A2 (en) use of at least one compound, peptide, and pharmaceutical formulation.
NO20083630L (en) New pyridine derivatives
BRPI0922233A2 (en) compounds, pharmaceutical compositions and methods for use in the treatment of metabolic syndromes.
EP2153831A4 (en) Anti-fatigue agent and oral composition each comprising andrographolide as active ingredient
BRPI0807078A2 (en) COMPOUND AND PHARMACEUTICAL FORMULATION
BRPI1009392A2 (en) "pharmaceutical formulation, and use of a pharmaceutically effective amount of a pharmaceutical formulation."
CL2007002207A1 (en) COMPOUNDS DERIVED FROM SULFONYLAMINES; PHARMACEUTICAL COMPOSITION; AND USE OF COMPOUNDS IN THE TREATMENT OF GLAUCOMA.
BRPI0917681A2 (en) Compound and pharmaceutical composition
BR112012003800A2 (en) composition, peptide, and pharmaceutical formulation.
BRPI0911772A2 (en) compound, pharmaceutical composition, and use of the compound.
CL2007001838A1 (en) COMPOUNDS DERIVED FROM 4-OXOQUINOLINE; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND FOR THE PRODUCTION OF AN ANTI-HIV AGENT.
BRPI1009823A2 (en) "composition comprising a drug dispensing system, a first and a second composition set, and a kit."
BRPI0717369A2 (en) COMPOUND, MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND.